bioaccess®

bioaccess® is a U.S.-based Contract Research Organization (CRO) specializing in accelerating early-phase clinical trials in Medtech, Biopharma, and Radiopharma. Operating across Latin America, Eastern Europe, and Australia, we provide end-to-end services including feasibility, regulatory approvals, site selection, project management, and patient recruitment. With faster timelines, cost savings, and FDA/EMA-ready data, BioAccess LA empowers startups to bring innovative therapies to market efficiently and globally.